Chagas disease is a parasitic infection caused by protozoan Trypanosoma cruzi that affects approximately 6e7 million people worldwide. Benznidazole is the only drug approved for treatment during the acute and asymptomatic chronic phases; however, its efficacy during the symptomatic chronic phase is controversial. The present work reports the synthesis and anti-T. cruzi activities of a novel series of phthalimido-thiazoles. Some of these compounds showed potent inhibition of the trypomastigote form of the parasite at low cytotoxicity concentrations in spleen cells, and the resulting structure-activity relationships are discussed. We also showed that phthalimido-thiazoles induced ultrastructural alterations on morphology, flagellum shortening, chromatin condensation, mitochondria swelling, reservosomes alterations and endoplasmic reticulum dilation. Together, these data revealed, for the first time, a novel series of phthalimido-thiazoles-structure-based compounds with potential effects against T. cruzi and lead-like characteristics against Chagas disease.
Introduction
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi (T. cruzi). Approximately 6e7 million people are estimated to be infected worldwide, mostly in Latin America, where Chagas disease is endemic [1] .
Despite the efforts of many investigators to research new antiChagas drugs, only one drug is currently used in therapy, benznidazole (Bdz) [2, 3] . Current chemotherapy for Chagas disease is unsatisfactory due to the limited efficacy of Bdz, particularly during the chronic phase, with frequent side effects that can lead to discontinuation of treatment [4] .
One pragmatic way to improve the quality of both the candidate drugs and screening collections is by improving the quality of the building blocks (reagents) that are used to synthesize them. Our strategic program focused on substructures and properties that are known to have imparted biological activity and good 'drug-like' properties previously. Among the chemical groups explored for anti-Chagas activity, thiazolyl hydrazones are noteworthy because of their wide biological, especially anti-parasitic, activities [5e8].
Caputo et al. have demonstrated trypanocidal activity for a series of 4-arylthiazolylhydrazones [9] , which have broad and potent activities for all forms of the parasite.
Our efforts toward new antichagasic drugs since 2006 have led us to develop a variety of thiosemicarbazones and 1,3-thiazolyl hydrazones as trypanocidal agents [4,7,10e14] . In continuation of our search for bioactive molecules, we envisaged that the derivatization of the thiosemicarbazone group into a thiazole moiety would generate novel templates that are likely to exhibit anti-T. cruzi activity [4] . However, much effort has been invested to identify the key differences between drugs and other organic compounds. Highquality libraries are expected to exhibit drug-likeness to produce compounds with desirable pharmacokinetic and safety profiles. The phthalimide functional group has been used as an important tool in organic synthesis because it protects against unwanted reactions. Many research teams have used this nucleus as a building block to improve compound quality. In fact, phthalimide derivatives have shown a broad spectrum of pharmacological properties, such as analgesic [15] , anticonvulsant [16] , antitubercular [17, 18] , hypolipidaemic [18] , anxiolytic [15] , anti-inflammatory [15] , antimicrobial [17, 19, 20] and antipsychotic [21] .
For this reason, our research group has explored the pharmacological properties of phthalimide derivatives. As a result, bioactive prototypes were identified with potent anti-inflammatory [22] , anti-proliferative [23] , immunomodulatory [22, 24, 25] , antitumor [23] , antiangiogenic [26] and schistosomicidal properties [27] , Indeed, Santiago et al. identified phthalimido-thiazole derivatives with potent schistosomicidal activities. The phthalimide LpQM-45 caused significant ultrastructural changes, including destruction of the integument in both male and female worms [27] , however, their antichagasic properties have not been explored.
Considering the promising results achieved by compounds bearing a thiazole ring and phthalimides nuclei, they were chosen as common pharmacophores that exist in diverse drug classes. In this way, we synthesized a set of molecules with phthalimide and thiazole nucleus. In this synthetic design of a substructure-based compound library, substituents around the phenyl ring attached at C4 in the thiazole ring (compounds 2b-n) were explored. In addition, a spacer group between phthalimide and the thiazole ring was inserted and a phenyl group at N3 of the thiazole ring was also introduced (6b-l). To investigate the influence of the phthalimido moiety at the anti-T. cruzi activity, 26 new compounds were tested in vitro against the T. cruzi parasite epimastigote and trypomastigote forms. Ultrastructural studies and flow cytometry analysis were also investigated ( Fig. 1 ).
Results and discussion

Chemistry
Initially, 14 phthalimido-thiazoles (2a-n) were synthesized in a two-step reaction, following the procedures reported by Pessoa et al. [25] . Firstly, a reaction of phthalic anhydride with thiosemicarbazide, in DMF under reflux for 4 h, with a catalytic amount of DMAP, led us to compound 1. The synthesis of the series 2a-n was performed via Hantsch cyclization between compound 1 and the appropriate a-halogenated ketone (1,3-dichloroacetone for compound 2a), under ultrasound irradiation, at room temperature (rt) for 1 h. This reaction condition led to average yields from 36 to 65%. To synthesize the series 6a-l, was followed the reaction protocol reported by Cardoso et al. [23] . The desired compounds 6a-l were obtained by the reaction of Intermediate 5b (or 5a, for compound 6a) with the appropriate a-halogenated ketone (1,3-dichloroacetone for compound 6a), via Hantsch cyclization, leading good yields (46e82%) (Scheme 1). All the synthesized compounds were well characterized by infrared (IR), nuclear magnetic resonance ( 1 H, 13 C NMR), mass spectroscopy (ESI-TOF) and, in case of compounds 2e, 2f and 2g, by single crystal X-ray diffraction analysis (Fig. 2) . The 1 H NMR spectra of some compounds showed that phthalimido-thiazoles 6a-l are composed by diastereomers. Next, we aimed to define the configuration of the major isomer by crystallographic analysis. However, we did not succeed in crystallizing phthalimido-thiazoles 6a-l suitable for X-ray analysis. Based on previous crystallized compounds by our group, we suggest that the major isomer formed present the E-Z configuration (Fig. 3) . Indeed, hydrazine double-bond C2¼N2 is commonly assigned as E configuration [4, 23, 28] . Concerning the exocyclic double-bond N3¼C3, we suggest that the predominant configuration is in Zconfiguration [7, 29] . Besides, a representative 1 H-NMR spectrum of compound 6i is presented in Supplementary Material.
Anti-T. cruzi evaluation
Initially, compounds 2a-n were planned to improve the trypanocidal activity and cytotoxic tolerance with the cyclization of phthalimido-thiosemicarbazone to the phthalimido-thiazole ring. From the results, it was observed in most of the cases that new phthalimido-thiazoles showed high cytotoxic activity in spleen cells. In opposition, only compounds 2i and 2j showed low cytotoxicity.
Concerning trypanocidal activity for epimastigotes, it is observed that 16 compounds (of 28) present better potency than Benznidazole (Table 1) . Among series 2a-n, compound 2i was the most active, among the series and the entire work. The most active compound in series 6 is 6k, a 3-NO 2 derivative, presenting an IC 50 of 6.0 mM. Observing compounds with withdrawer substituents (2e-h, 2k-n), compound 2,4-dichloro substituted (2m) was the most active. It analogue disubstituted 3,4-dichloro (2l) present lower trypanocidal activity and high toxicity for BALB/c mice spleen cells, denoting that the orientation of the substituents is important for the activity. Observing bulk substituted compounds (phenyl, 2-naphthyl and 4-biphenylyl), in series 2a-n, a relationship of LogP and trypanocidal activity (Fig. 4) is observed, being compound 2i the most active of this sub-series.
The trend of bulky substituents (LogP) observed for series 2a-n is not observed for series 6a-l, being compound 6k (3-NO 2 ) the most active of the series 6a-l.
When comparing the trypanocidal activity against the trypomastigote form of the series 2a-n of phthalimido-thiazole derivatives, compound 2j was found to be the most potent of this sub- series, presenting lower cytotoxic levels (269.2 mM) and equipotent trypanocidal activity compared with Bdz (4.7 vs 6.3 mM) (Table 1) .
No clear correlation was observed between the substituents at the thiazole C4 and the biological activity. For example, 2-naphthyl is a bulky substituent present in 2j; however, compound 2i, which was also substituted with a bulky biphenylyl substituent, did not present good activity. The influence of the phenyl linked at C4 in the thiazole ring was also investigated, but no noticeable improvement in activity was observed. Comparing compound 2a with the phenyl-unsubstituted compound 2b, a decrease in trypanocidal activity and higher cytotoxicity were observed, while the phenylsubstituted compounds maintained or increased both activities.
A structural optimization involving addition of a spacer group (eCH 2 eCH ¼ ) between the phthalimide and the thiazole core was performed in order to increase the flexibility of the molecules and to investigate its influence on biological activities (Fig. 5) . A substitution of H with phenyl at N3 was also performed to explore the influence of bulky substituents based on the results of compounds 2i and 2j, both substituted with 4-biphenylyl and 2-naphthyl at C4, respectively, which displayed lower cytotoxicity.
Compounds that contained a spacer group (6a-l) and phenyl at N3 (6b-l) in general showed low cytotoxicity profiles and improved trypanocidal activity for trypomastigote form, highlighting compounds 6a (2.2 mM), 6h (3.2 mM), 6j (0.5 mM) and 6k (0.9 mM). In fact, compound 6j presented a selective index (SI, for trypomastigote form) of 409.8, which was approximately 27-fold more selective than Bdz (SI: 15.25), the standard drug in clinical use. As observed in the 2a-n series, the compound substituted at C4 with chloromethyl (6a, 2.2 mM) was more active than compounds substituted with phenyl (6b, 8.8 mM); indeed, phenyl-substituted compounds 6j (0.5 mM) and 6k (0.9 mM) were more active than 6a. Comparing compound 6a with 2a, which were both substituted with chloromethyl at C4 with the unique difference of the presence of the spacer group in 6a, a 24-fold improvement in trypanocidal activity (2.2 vs 54.4 mM) and a 4-fold increase in cytotoxicity (73.7 vs 17.0 mM) were observed for 6a. Compounds 6k and 6h, both nitro-substituted compounds at the meta and para positions, respectively, presented high trypanocidal activity with selective indexes of 114.9 and 64.6, respectively (Table 1) . Compound 6e (with the electron withdrawing fluorine substituent) and 6i (with 4-biphenylyl substituent) did not present good trypanocidal activity. Compound 6j, which was substituted with the bulky substituent 2-naphthyl, presented the highest trypanocidal activity.
The SAR studies revealed that a series of phthalimido-thiazoles were interesting anti-T. cruzi compounds, which five new compounds showed low cytotoxicity in spleen cells of BALB/c mice and anti-trypanocidal activity against the trypomastigote form of the parasite.
Congreve et al. proposed a rule-of-three (RO3) [30] representing a set of guidelines for constructing a fragment library (molecular weight, <300; cLogP, 3; number of hydrogen bond donors, 3; and the number of hydrogen bond acceptors, 3). Recently, RO3 was accredited by most medicinal chemists and could be useful for efficient fragment selection [31] . As seen in Table 2 , the phthalimide and thiazole fragments are in agreement with RO3.
The trypanocidal profile of these phthalimido-thiazoles revealed a group of privileged structure-based compounds that can be used as building blocks to obtain new lead-like compounds. They possess some structural features, such as lower molecular weights, decreased complexity and decreased hydrophobicity, which are consistent with lead-like characteristics. These compounds can be used to produce structurally simple leads with modest activity, allowing for further derivatization at a later stage to improve affinity and selectivity while retaining drug-like characteristics.
Ultra structural studies
In view to investigate the effects of phthalimido-thiazoles on parasite morphology, compound 6k, one of the most active compound of this work, was selected. The ultrastructural effects of 6k on trypomastigotes after 24 h were analysed by TEM and SEM at the IC 50 concentration and twice the IC 50 value (Table 1) , and the ultrastructural analysis showed several morphological alterations (Fig. 6 ).
SEM analysis revealed that treatment with 0.9 mM (1 Â IC 50 ) and 1.8 mM (2 Â IC 50 ) of 6k caused blebs in the flagellum and shortening of the flagellum with a drastic decrease in the number of parasites, respectively ( Fig. 6BeC) , while the control group retained its typical morphology (Fig. 6A) .
TEM analysis revealed that untreated parasites showed normal ultrastructural morphologies of organelles, such as kinetoplast, nucleus, nucleolus, flagellum, ribosomes and microtubule membranes ( Fig. 6D) , whereas parasites treated with 0.9 mM of 6k showed alterations in the reservosomes, and a large number of cells showed intense cytoplasmic vacuolization. In addition, alterations of the parasite morphology, large nuclear chromatin clumps that resembled the nuclei of apoptotic cells, mitochondria swelling and loss of cytoplasmic material were observed (Fig. 6EeF) . The parasites treated with 1.8 mM of 6k showed alterations of parasite morphology, abnormal chromatin condensation, dilated endoplasmic reticula, intense vacuolization in the cytoplasm, swelling of the kinetoplast and alterations in the reservosomes (Fig. 6G) .
Ultrastructural analysis was applied to explore the damages induced by the drugs in trypomastigotes T. cruzi parasites and clearly showed severe morphological changes, of which intense cytoplasmic vacuolization, chromatin condensation, alterations in the reservosomes and swelling of the mitochondria were most frequent. These ultrastructural alterations are similar to those previously reported [32e36] . The ultrastructural evaluation indicated a dose-dependent action because a drastic decrease in the number of parasites was observed with increasing drug doses.
Flow cytometry analysis
After confirming that 6k was an antiparasitic compound that affected ultrastructural cellular organization, we sought to determine whether 6k caused parasite cell death. To this end, Y strain trypomastigotes were treated with different concentrations of 6k. After 24 h incubation, parasite cells were stained with propidium iodide (PI) and annexin-V and analysed by flow cytometry. The results are shown in Fig. 7 .
Compared with untreated cells, benznidazole resulted in PIstaining in a concentration-dependent manner, while no significant annexin-V staining was observed (data not shown). At 25 mM, benznidazole induced 56 ± 6% PI-staining in parasite cells. At the same concentration, treatment with compound 6k induced PIstaining in 11 ± 3% of parasite cells. No PI or annexin-V staining were observed under treatment with 6k (data not shown). Therefore, these phthalimido-thiazoles do not destroy parasite cells by classical cell death processes. Based on electronic microscopy observations, it is possible that phthalimido-thiazoles decrease parasite viability by altering cytosol organization, mainly by causing intense cytoplasmic vacuolization.
Conclusion
Twenty-six phthalimido-thiazoles were obtained in reasonable yields using a simple methodology. Compounds with important trypanocidal activity, especially compounds 2j, 6a, 6h, 6j and 6k, were identified. Flow cytometry and ultrastructural studies showed that compound 6k did not kill the parasite via necrosis or apoptosis; however, it promoted several morphological changes in the parasite. Compound 6j, the most potent trypanocidal agent identified in this work, presented a selective index of 409, which was approximately 26-fold more selective than Bdz, the standard drug in clinical use. Our results indicated that phthalimidothiazoles can be used as building blocks to design promising candidates to treat Chagas disease.
Experimental section
Chemistry
Equipment and reagents
All reagents were used as purchased from commercial sources (SigmaeAldrich, Acros Organics, Vetec or Fluka). Reaction progress was followed by thin-layer chromatography (TLC) analysis (Merck, silica gel 60 F 254 in aluminium foil). The purities of the target compounds were confirmed by combustion analysis (for C, H, N, 
, and coupling constants (J) in hertz. Mass spectrometry experiments were performed on a LC-IT-TOF (Shimadzu). Unless otherwise specified, ESI was conducted in positive ion mode. Typical conditions were as follows: capillary voltage of 3 kV, cone voltage of 30 V, and peak scan between 50 and 1000 m/z. IR spectra were recorded with a Bruker model IFS66 FT-IR spectrophotometer using KBr pellets.
General procedure for the syntheses of 2a-n
The compound 1 was prepared by reacting commercially available thiosemicarbazide with the phthalic anhydride (1:1 mol ratio) using DMF under reflux in the presence of a catalytic amount of DMAP, for 4 h. This reaction condition led to satisfactory yield (58%). The phthalimido-thiazoles (2a-n) were prepared via cyclization between 1 and respective a-halogenated ketone (1,3-dichloroacetone for compound 2a), via ultrasound irradiation for 1 h, as previously related [4] . These reactions proceeded well under ultrasound conditions at room temperature using 2-propanol as solvent, resulting in satisfactory yields (36e65%) and shorter reaction times (60 min in most cases). 
Procedure for the syntheses of intermediate compounds 5a-b
Compound 3 was prepared by the condensation of commercially available aminoacetaldehyde diethyl acetal with the phthalic anhydride (1:1 mol ratio), using toluene under reflux, in the presence of a catalytic amount of DMAP (yield 52%) for 2 h. In the next step, 2-(2,2-diethoxyethyl)isoindoline-1,3-dione (3) underwent acid hydrolysis (sulphuric acid at 70%) in reflux for 2 h. After the reaction was completed, it was allowed to reach at room temperature and was then cooled to induce precipitation. The formed precipitate was filtered on a sintered funnel with distilled water, yielding 55% of the pure product. For the synthesis of 5a and 5b, 2-(1,3-dioxoisoindol-2-yl) acetaldehyde (4) reacted with thiosemicarbazide (in the ratio 1:1) (for 5a) or 4-phenyl-3-thiosemicarbazide (for 5b), in ethanol, under reflux with catalytic amount of HCl (4 drops) for 4 h. The reactions were followed by thin layer chromatographic plate analysis. The formed precipitate was filtered on a sintered funnel with ethanol to yield the pure product (yield 76% for 5a and 70% for 5b). 
Procedure for the synthesis of 6a
In a round bottom flask was added 2-(2-(1,3-dioxoisoindolin-2-yl) ethylidene)hydrazinecarbothioamide (5a), 1,3-dichloroacetone and DMF. The reaction mixture was stirred at room temperature for about 1 h. The reaction was followed by thin layer chromatographic plate. After addition of distilled water, the pure product precipitates. 
General procedure for the synthesis of 6b-l
In round bottom flask was added 2-(2-(1,3-dioxoisoindolin-2-yl)ethylidene)-N-phenyl-hydrazine-carbothioamide (5b), the respective a-halogenated ketone and 2-propanol. The reaction mixture was kept under magnetic stirring, at room temperature, for 1 h. The reactions were followed by thin layer chromatographic plate. The formed precipitate was filtered on sintered funnel with distilled water, yielding the pure product. 
X-ray analysis
X-ray diffraction data collections were performed on an EnrafNonius Kappa-CCD diffractometer (95 mm CCD camera on kgoniostat) using graphite monochromated MoKa radiation (0.71073 Å) at room temperature. Data were collected using the COLLECT software [37] up to 50 (2q). The final unit cell parameters were based on 15666, 9327, and 12333 reflections to 2e, 2f and 2g, respectively. Integration and scaling of the reflections as well as the corrections for Lorentz and polarization effects were performed with the HKL DENZO-SCALEPACK system of programs [38] . The compound structures were solved by direct methods with SHELXS-97 [39] . The model was refined by full-matrix least squares on F2 using SHELXL-97 [39] . The program ORTEP-3 [40] was used for graphic representations, and the program WinGX [41] was used to prepare the material for publication. All H atoms were located by geometric considerations placed (CeH ¼ 0.93 Å; NeH ¼ 0.86 Å) and refined using a riding model with Uiso(H) ¼ 1.5Ueq(C-methyl) or 1.2Ueq(other). An Ortep-3 diagram of the molecules is shown in Fig. 2 , and Table S1 shows the main crystallographic data. Crystallographic data (excluding structure factors) for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary material (No. CCDC 1411254, 1411262 and 1411263).
Biological assays of toxicity to splenocytes
Splenocytes from BALB/c mice were divided into a 96 well plate at a density of 5 Â 10 6 cells per well in RPMI-1640 medium containing 10% inactivated Foetal Bovine Serum (FBS). Each chemical inhibitor was dissolved in DMSO at a concentration of 10 mg/mL, and then the sample was serially diluted in RPMI-1640 medium supplemented with 10% FBS at concentrations of 1.0, 5.0, 10, 25, 50
and 100 mg/mL, in triplicate. As a positive control, saponin was used at a concentration of 0.1 mg/mL, while RPMI-1640 medium supplemented with 10% FBS and DMSO was used as a negative control.
A total of 1.0 mCi of 3H-thymidine was added to each well, and the plate was incubated for 24 h at 37 C and 5% CO2. The plate was then read in the counter beta irradiation reader (Multilabel Reader, Finland), and the percent incorporation of tritiated thymidine was determined. Cells that were not treated with drugs (negative controls) were calculated as 100% of tritiated thymidine incorporation (100% viable cells). For cells treated with saponin, cell viability was 5%. When the percentage of incorporation was higher than 90%, the concentration of the drug was regarded as nontoxic to splenocytes.
Antiproliferative activity for the epimastigote form
Epimastigotes of Dm28c strain were distributed into a 96 well plate to a final density of 10 6 cells per well. Each chemical inhibitor was dissolved in the respective wells, in triplicate. Benznidazole was used as positive controls in this assay. The plate was then cultivated for 4 days at 27 C. After this time, aliquots from each well were collected, and the number of parasites was calculated in a Neubauer chamber. Epimastigotes not treated with the chemical inhibitors (negative control) were assumed as 100% the number of parasites. The doseeresponse curves were determined, and the IC 50 values were calculated using at least five concentrations (data points) and a nonlinear equation (Prism, version 4.0).
Toxicity to trypomastigotes
Strain Y trypomastigotes were collected from Vero cell supernatants and distributed in a 96 well plate to a final density of 4 Â 10 5 cells per well. Each chemical inhibitor was added to the wells, in triplicate. Benznidazole was used as positive controls in this assay. The plate was then cultivated for 24 h at 37 C and 5% CO2. After this time, aliquots from each well were collected, and the number of viable parasites (i.e., with apparent motility) was counted in a Neubauer chamber. The wells that did not receive the chemical inhibitors were assumed as 100% the number of viable parasites. The doseeresponse curves were determined, and the IC 50 values were calculated by nonlinear regression (Prism, version 4.0) using at least seven concentrations (data points).
Ultrastructural studies
The parasites were cultured for 24 h in RPMI 1640 medium (SigmaeAldrich, St. Louis, MO, USA) buffered to pH 7.5 and supplemented with HEPES (20 mM), 10% foetal bovine serum, penicillin (100 U/mL), and streptomycin (100 mg/mL) containing the compound 6k at the IC 50 concentration and twice the value of IC 50 . The parasites were collected, washed in PBS and fixed with 2.5% glutaraldehyde, 4% formaldehyde, and 0.1 M cacodylate buffer at pH 6.8. They were then postfixed in 2% osmium tetroxide (OsO 4 ) in a 0.1 M cacodylate buffer at pH 6.8 and processed for routine transmission electron microscopy (TEM) and scanning electron microscopy (SEM).
For SEM analysis, the parasites were dehydrated in graded ethanol and dried by the critical point method with CO 2 . The samples were mounted on aluminium stubs, coated with gold and examined under a JEOL-5600LV microscope.
For TEM analysis, the parasites were dehydrated in a graded series of acetone and finally embedded in epon. Sections were stained with uranyl acetate and lead citrate and observed with Tecnai spirit G2 Biotwin microscope.
Propidium iodide and annexin V staining
Trypomastigotes (1 Â 10 7 ) were incubated for 24 h at 37 C in the absence or presence of compound 6k. After incubation, the parasites were labelled with propidium iodide (PI) and annexin V using the annexin V-FITC apoptosis detection kit (SigmaeAldrich), according to the manufacturer's instructions. Acquisition and analyses were performed using a FACS Calibur flow cytometer (Becton Dickinson, CA, USA) with FlowJo software (Tree Star, CA, USA). A total of 30,000 events were acquired in the region previously established as trypomastigote forms of T. cruzi. Two independent experiments were performed.
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